Do you want to read an article? Please log in or register.
Diagnostic Yield and Safety of Repeat Bronchoscopy in Pulmonary Disease: A Five-Year Retrospective Analysis
Lung Cancer
RECOMMENDED
Related content
RECOMMENDED
COPDFurther Publications
Global, regional, and national burden of chronic obstructive pulmonary disease and its attributable risk factors from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res
Wang Z, Lin J, Liang L, Huang F, Yao X, Peng K, Gao Y, Zheng J
doi: 10.1186/s12931-024-03051-2
RECOMMENDED
Lung CancerPleural Diseases
Diagnostic performance of shape-sensing robotic-assisted bronchoscopy for pleural-based and fissure-based pulmonary lesions
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Thorax
Fernandez-Bussy S, Yu Lee-Mateus A, Barrios-Ruiz A, Valdes-Camacho S, Lin K, Ibrahim MI, Vaca-Cartagena BF, Funes-Ferrada R, Reisenauer J, Robertson KS, Hazelett BN, Chadha RM, Abia-Trujillo D
doi: 10.1136/thorax-2024-222502
RECOMMENDED
Cough
Clinical Characteristics and Diagnostic Practices in Nontuberculous Mycobacterial Pulmonary Disease: Insights from Denmark
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Dahl VN, Fløe A, Rudolf F, van Ingen J, Andersen AB, Wejse CM, Lillebaek T
doi: 10.1016/j.rmed.2025.108055
Pulmonary Hypertension
Global, regional, and national burden of pulmonary arterial hypertension, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
Lancet Respir Med
GBD 2021 Pulmonary Arterial Hypertension Collaborators
doi: 10.1016/S2213-2600(24)00295-9
RECOMMENDED
COPDInterstitial Lung Disease
Pulmonary Rehabilitation and Functional Independence: Impact on Survival in Patients with Fibrotic Interstitial Lung Disease or Chronic Obstructive Pulmonary Disease
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Elmiger A, Marcin T, Bovet L, Brun P, Guler SA
doi: 10.1016/j.rmed.2024.107933
Lung CancerPleural Diseases
A Prospective, Multicenter Evaluation of Safety and Diagnostic Outcomes with Robotic-Assisted Bronchoscopy: Results of the Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors of the Lung (TARGET) Trial
Chest
Murgu S, Chen AC, Gilbert CR, Sterman DH, Pederson D, Rafeq S, Laxmanan B, Schwiers ML, Connelly J, Benz HL, Yasufuku K, Silvestri GA, TARGET Investigators
doi: 10.1016/j.chest.2025.04.022
RECOMMENDED
COPD
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Singh D, Brightling CE, Rabe KF, Han MK, Christenson SA, Drummond MB, Papi A, Pavord ID, Molfino NA, Almqvist G, Kotalik A, Hellqvist Å, Gołąbek M, Sindhwani NS, Ponnarambil SS, COURSE study investigators
doi: 10.1016/S2213-2600(24)00324-2
COMMENTED
COPD
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Dakin P, Maloney J, Lu X, Bauer D, Bansal A, Abdulai RM, Robinson LB
doi: 10.1016/S2213-2600(24)00409-0
RECOMMENDED
ARDSInterstitial Lung Disease
Initial Respiratory System Involvement in Juvenile Idiopathic Arthritis with Systemic Onset Is a Marker of Interstitial Lung Disease: The Results of Retrospective Cohort Study Analysis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med
Belozerov KE, Isupova EA, Solomatina NM, Gaidar EV, Kaneva MA, Chikova IA, Kalashnikova O, Kuznetsova AA, Ivanov DO, Kostik MM
doi: 10.3390/jcm13133843